Rigel Pharmaceuticals Newsroom

Rigel Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results.

Benzinga05:59

Rigel Pharmaceuticals | 10-Q: Quarterly report

SEC05:14 · Announcements

Rigel Pharmaceuticals GAAP EPS of $0.70 Beats by $0.63, Revenue of $55.3M Beats by $13.37M

Seeking Alpha05:11

Express News | Rigel Pharmaceuticals Q3 Net Income USD 12.4 Million Vs. IBES Estimate USD 910.2 Thousand

Breakings05:01

Rigel Pharmaceuticals 3Q Rev $55.3M >RIGL

Dow Jones05:01

Here Are the Major Earnings After the Close Today

Seeking AlphaNov 7 23:00

Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition

PR NewswireNov 5 22:05

Europäischer Marktführer in Der Kontaminationskontrolle Hat Auf Der Jährlichen Strategiesitzung Die Strategien Vorgestellt, Die Seine Globale Expansion in Den Nächsten Fünf Jahren Leiten Werden

PR NewswireNov 4 22:00

Líder Europeo En Control De La Contaminación Ha Presentado Las Estrategias Que Guiarán Su Expansión Global

PR NewswireNov 4 22:00

Le Leader Européen Du Contrôle De La Contamination a Présenté Les Stratégies Qui Guideront Son Expansion Mondiale Au Cours Des Cinq Prochaines Années Lors De Sa Réunion Stratégique Annuelle

PR NewswireNov 4 22:00

Earnings Preview: RIGL to Report Financial Results Post-market on November 07

$Rigel Pharmaceuticals(RIGL.US)$ is scheduled to release its financial results post-market on November 07 ET. Earnings PreviewAnalysts estimate $Rigel Pharmaceuticals(RIGL.US)$ to post revenue of USD4

Futu NewsNov 2 09:00

Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update

PR NewswireOct 31 20:05

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57

Futu NewsOct 25 18:31 · Ratings

Express News | Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for Gavreto® (Pralsetinib)

BreakingsOct 25 04:36

Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO (Pralsetinib)

PR NewswireOct 25 04:35

Optime Care Expands Partnership With Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE

GlobeNewswireOct 16 22:00

Express News | Optime Care Expands Partnership With Rigel Pharmaceuticals to Include Commercial Distribution for Tavalisse®

BreakingsOct 16 22:00

Express News | Rigel Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsOct 4 20:05

Rigel Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR NewswireOct 4 20:05

Rigel (RIGL) Surges 19.7%: Is This an Indication of Further Gains?

Zacks Sep 25 15:45